This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

phagenesis

Phagenesis Expands Series B Financing to $17 million 22 May 2013

Manchester, UK – 22 May 2013 - Phagenesis, the world’s leading company in the treatment of dysphagia, has expanded its Series B financing to $17m.

> Read More

quantumdx

QuantuMDx and Genome Institue of Singapore announce collaboration to develop Asia-specific assays on QuantuMDx's Q-POC™ 21 May 2013

A*STAR's Genome Institute of Singapore (GIS) has signed an agreement with QuantuMDx (QMDx), a UK-based biotech developing handheld diagnostics and whole genome sequencing devices. Under this collaboration, QMDx's wholly owned Singapore-based subsidiary QMDx Asia and GIS will develop Asia-specific point-of-care genetic tests for use with Q-POC™, QMDx's handheld point-of-care device.

> Read More

cogent

Life Science Talent Shines at new UK Skills Awards. Apprentices, graduates, employers, providers and leaders in the spotlight on skills 20 May 2013

250 guests gathered at London’s Grand Connaught Rooms to witness the inaugural UK Life Science Skills Awards, organised by Cogent, the strategic skills body for the science industries. The event, which took place on Thursday 16th May, saw 30 finalists and 11 winners, take to the stage to receive Awards across ten categories. Plus an extra, special Award for Excellence in Skills.

> Read More